Aromatase inhibitors: the journey from the state of the art to clinical open questions

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 14 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 20,745 followers.

RT @Senology: #Reviews: Aromatase inhibitors: the journey from the state of the art to clinical open questions https://t.co/69ng1pbU5V - F…

10 Jan 2024

Reply Repost Favourite

#Reviews: Aromatase inhibitors: the journey from the state of the art to clinical open questions https://t.co/69ng1pbU5V - Front Oncol - #senology #oncology #breast #cancer

10 Jan 2024

Reply Repost Favourite

RT @FrontOncology: New research: Aromatase inhibitors: the journey from the state of the art to clinical open questions: Breast cancer is a…

23 Dec 2023

Reply Repost Favourite

New research: Aromatase inhibitors: the journey from the state of the art to clinical open questions: Breast cancer is a major cause of death among females. Great advances have been made in treating this disease, and aromatase inhibitors (AIs)… https://t.c

23 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.